CSHNX
Price
$10.37
Change
-$0.35 (-3.26%)
Updated
Apr 10 closing price
Net Assets
1.02B
GLPSX
Price
$36.38
Change
-$0.98 (-2.62%)
Updated
Apr 10 closing price
Net Assets
1.59B
Ad is loading...

CSHNX vs GLPSX

Header iconCSHNX vs GLPSX Comparison
Open Charts CSHNX vs GLPSXBanner chart's image
NYLI Cushing® MLP Premier Investor Class
Price$10.37
Change-$0.35 (-3.26%)
VolumeN/A
Net Assets1.02B
Goldman Sachs MLP Energy Infras R6
Price$36.38
Change-$0.98 (-2.62%)
VolumeN/A
Net Assets1.59B
CSHNX vs GLPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSHNX vs. GLPSX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSHNX is a Hold and GLPSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GLPSX has more cash in the bank: 1.59B vs. CSHNX (1.02B). CSHNX (6.39) and GLPSX (6.13) have matching dividends . CSHNX was incepted earlier than GLPSX: CSHNX (11 years) vs GLPSX (7 years). GLPSX (2.07) is less costly to investors than CSHNX (1.48). GLPSX is a more actively managed with annual turnover of: 103.00 vs. CSHNX (25.00). CSHNX has a lower initial minimum investment than GLPSX: CSHNX (2500) vs GLPSX (5000000). CSHNX annual gain was more profitable for investors over the last year : 15.27 vs. GLPSX (11.11). GLPSX return over 5 years is better than : 249.55 vs. CSHNX (221.39).
CSHNXGLPSXCSHNX / GLPSX
Total Expense Ratio1.482.0771%
Annual Report Gross Expense Ratio1.482.0771%
Fund Existence11 years7 years-
Gain YTD-7.731-2.033380%
Front Load5%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B1.59B64%
Annual Yield % from dividends6.396.13104%
Returns for 1 year15.2711.11137%
Returns for 3 years53.0556.9393%
Returns for 5 years221.39249.5589%
Returns for 10 years10.45N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBRX5.890.19
+3.33%
Forte Biosciences Inc
AMLX3.49N/A
N/A
Amylyx Pharmaceuticals
NTST15.06-0.04
-0.26%
NetSTREIT Corp
ADSK256.92-6.61
-2.51%
Autodesk
FSK18.67-0.92
-4.70%
FS KKR Capital Corp